We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 1,022 results from 1 sources
https://web.expasy.org/cellosaurus/CVCL_0031

Cite this: (NCBI_Iran Cat# C135, RRID:CVCL_0031)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ); ~38 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.Glu545Lys (PubMed=17088437; PubMed=28889351). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Misspelling: MFC-7; Occasionally. Discontinued: ATCC; CRL-12584. Discontinued: JCRB; NIHS0200. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0359

Cite this: (KCLB Cat# 30001, RRID:CVCL_0359)
Organism: Homo sapiens
Disease: Bladder carcinoma
Category: Cancer cell line
Comment: Part of: BLA-40 bladder carcinoma cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: PTEN genetic alteration cell panel (ATCC TCP-1030). Part of: UBC-40 urothelial bladder cancer cell line index. Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: TERT c.228C>T (-124C>T); in promoter (PubMed=24035680). Sequence variation: TP53 p.Glu271Lys (PubMed=9850064). Omics: CNV analysis. Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0419

Cite this: (ATCC Cat# HTB-132, RRID:CVCL_0419)
Organism: Homo sapiens
Disease: Breast adenocarcinoma
Category: Cancer cell line
Comment: Group: Triple negative breast cancer (TNBC) cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: EGFR genetic alteration cell panel (ATCC TCP-1027). Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 62 hours (NCI-DTP); ~30-40 hours (DSMZ); ~47 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=15677628; Sanger). Sequence variation: Homozygous for TP53 p.Arg273His (ATCC; PubMed=16541312; PubMed=28889351). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: CLS; 300279. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0527

Cite this: (KCLB Cat# 30070, RRID:CVCL_0527)
Organism: Homo sapiens
Disease: Cutaneous melanoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-522. Doubling time: 70 hours (PubMed=25984343); 25.2 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for BRAF p.Val600Glu (c.1799T>A) (PubMed=17088437; PubMed=24576830). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from metastatic site: Axillary lymph node.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0597

Cite this: (NIH-ARP Cat# 9938-10, RRID:CVCL_0597)
Organism: Homo sapiens
Disease: Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: MD Anderson Cell Lines Project. Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel. Characteristics: EBV-negative. Doubling time: 20.4 +- 1.5 hours (PubMed=9225077); 14 hours (PubMed=20922763); ~48 hours (DSMZ). Sequence variation: TP53 p.Ile254Asp (PubMed=1915267; PubMed=2052620; PubMed=8344493). Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Ascites.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1732

Cite this: (ATCC Cat# HTB-117, RRID:CVCL_1732)
Organism: Homo sapiens
Disease: Vulvar squamous cell carcinoma
Category: Cancer cell line
Comment: Part of: COSMIC cell lines project. From: Scott and White Clinic; Temple; Texas; USA. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: SNP array analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1719

Cite this: (ATCC Cat# CRL-2175, RRID:CVCL_1719)
Organism: Homo sapiens
Disease: Renal cell carcinoma
Category: Cancer cell line
Comment: Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. From: Scott and White Clinic; Temple; Texas; USA. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1726

Cite this: (CLS Cat# 300422/p547_SW-684, RRID:CVCL_1726)
Organism: Homo sapiens
Disease: Fibrosarcoma
Category: Cancer cell line
Comment: Part of: COSMIC cell lines project. From: Scott and White Clinic; Temple; Texas; USA. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: SNP array analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (RCB Cat# RCB1640, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0031

Cite this: (DSMZ Cat# ACC-115, RRID:CVCL_0031)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ); ~38 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.Glu545Lys (PubMed=17088437; PubMed=28889351). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Misspelling: MFC-7; Occasionally. Discontinued: ATCC; CRL-12584. Discontinued: JCRB; NIHS0200. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (TKG Cat# TKG 0362, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0031

Cite this: (JCRB Cat# JCRB0134, RRID:CVCL_0031)
Organism: Homo sapiens
Disease: Invasive ductal carcinoma, not otherwise specified
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: JFCR45 cancer cell line panel. Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377). Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 31.2 hours (PubMed=22628656); 25.4 hours (NCI-DTP); ~50 hours, with a range of 30-72 hours (DSMZ); ~38 hours (PBCF). Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger). Sequence variation: Heterozygous for PIK3CA p.Glu545Lys (PubMed=17088437; PubMed=28889351). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: miRNA expression profiling. Omics: Myristoylated proteins analysis by proteomics. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Anecdotal: This is the first hormone-responsive breast cancer cell line to have been established. Anecdotal: Helen Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun (Sister Catherine Frances) at the Immaculate Heart of Mary Convent in Monroe, Michigan. Misspelling: MFC-7; Occasionally. Discontinued: ATCC; CRL-12584. Discontinued: JCRB; NIHS0200. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (Coriell Cat# GM03190, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (KCLB Cat# 10213, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (ECACC Cat# 85011437, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (BCRC Cat# 60192, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (NCBI_Iran Cat# C112, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (DSMZ Cat# ACC-78, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (Coriell Cat# GM17346, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0008

Cite this: (ICLC Cat# HTL95024, RRID:CVCL_0008)
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: Homozygous for CTNNB1 p.Ala5_Ala80del (c.14_241del228) (ATCC). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X